FLAAS
腺苷 5′-三磷酸腺苷 (ATP) 二钠盐 水合物
≥90%, bacterial (Corynebacterium sp), lyophilized powder
别名:
ATP 二钠 水合物
登录 查看组织和合同定价。
选择尺寸
关于此项目
线性分子式:
C10H14N5O13P3Na2 · xH2O
化学文摘社编号:
分子量:
551.14 (anhydrous basis)
UNSPSC Code:
12352208
eCl@ss:
32160414
PubChem Substance ID:
NACRES:
NA.26
EC Number:
213-579-1
MDL number:
产品名称
腺苷 5′-三磷酸腺苷 (ATP) 二钠盐 水合物, vial of ~1 mg ATP
SMILES string
Nc1ncnc2n(cnc12)[C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]3O
InChI
1S/C10H16N5O13P3.2Na.H2O/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20;;;/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20);;;1H2/q;2*+1;/p-2/t4-,6-,7-,10-;;;/m1.../s1
InChI key
NTBQNWBHIXNPRU-MSQVLRTGSA-L
biological source
bacterial (Corynebacterium sp)
assay
≥90%
form
lyophilized powder
packaging
vial of ~1 mg ATP
solubility
water: soluble, clear, colorless (1 vial + 0.1 mL)
storage temp.
−20°C
Quality Level
正在寻找类似产品? 访问 产品对比指南
Application
腺苷5′-三磷酸盐(ATP)二钠盐水合物用作：
- 生物发光法测定ATP的标准物
- 激酶缓冲液，以评估死亡相关蛋白激酶(DAPK2)与14-3-3-β之间的相互作用
- ATP比色测定的标准
Biochem/physiol Actions
5′-三磷酸腺苷通过清除TNF-α的分泌和促进白介素-10的分泌，发挥对炎症反应的抑制作用。
P2 嘌呤能激动剂；增加 Ca2+-激活的 K+ 通道的活性；ATP-依赖酶系统的底物
腺苷5′-三磷酸(ATP)是存在于生命系统中的一种核苷三磷酸。它控制着各种生物过程，如葡萄糖代谢、肌肉收缩和神经传递等。除此之外，ATP还是细胞重要的能量来源。ATP的应用对非小细胞肺癌的治疗可能有用。
Preparation Note
制备过程基本无钒。
每小瓶含 ~1.2mg Na2ATP • 3H2O，相当于 ~1.0mg ATP (2.0μmol)。标签上印有实际含量。
存储类别
11 - Combustible Solids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Randomized clinical trial of adenosine 5?-triphosphate in patients with advanced non-small-cell lung cancer
Agteresch HJ, et al.
Journal of the National Cancer Institute, 92(4), 321-328 (2000)
Necrostatin-1 attenuates mitochondrial dysfunction in neurons and astrocytes following neonatal hypoxia--ischemia
Chavez-Valdez R, et al.
Neuroscience, 219, 192-203 (2012)
Identification of novel death-associated protein kinase 2 interaction partners by proteomic screening coupled with bimolecular fluorescence complementation
Geering B, et al.
Molecular and Cellular Biology, 36(1), 132-143 (2016)
Jie Ge et al.
Journal of medicinal chemistry, 49(15), 4606-4615 (2006-07-21)
17-Allylamino-17-demethoxygeldanamycin (17-AAG)1 is a semisynthetic inhibitor of the 90 kDa heat shock protein (Hsp90) currently in clinical trials for the treatment of cancer. However, 17-AAG faces challenging formulation issues due to its poor solubility. Here we report the synthesis and
Francisco J Adrián et al.
Nature chemical biology, 2(2), 95-102 (2006-01-18)
Chronic myelogenous leukemia (CML) is a myeloproliferative disorder characterized at the molecular level by the expression of Bcr-abl, a 210-kDa fusion protein with deregulated tyrosine kinase activity. Encouraged by the clinical validation of Bcr-abl as the target for the treatment
相关内容
Instructions
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持